-

Consumer Watchdog Attorneys at Hagens Berman Warn John Muir Patients of Potential Overbilling

Law firm says Bay Area patients of any John Muir hospital or emergency room may have been overbilled thousands of dollars for drug tests

SAN FRANCISCO--(BUSINESS WIRE)--Attorneys at consumer-rights law firm Hagens Berman are warning Bay Area residents they may have been wrongfully charged thousands of dollars by John Muir Health hospitals or emergency rooms for drug tests for illicit drug use.

The unexpected charges for drug tests from John Muir Health amount to upwards of $6,000, according to attorneys. Even patients with insurance are left with huge co-pays and deductibles for services they did not request or consent to having performed.

Attorneys at the law firm say patients may have rights to their money back under consumer-protection laws.

If you received large and unexpected charges for a drug test after visiting a John Muir Health location, find out your rights to potential repayment.

Hagens Berman’s representation of consumers has earned it national recognition, and the firm has achieved more than $320 billion in settlements for its clients since its founding.

Your Patient Rights Against Billing Fraud

According to the firm, expensive and unexpected bills for drug tests may constitute fraud, and patients of John Muir hospitals may have consumer rights against these predatory billing practices.

Attorneys say all John Muir Health locations are under investigation, including Concord Medical Center, Walnut Creek Medical Center, Behavioral Health Center, San Ramon Regional Medical Center (Partner Hospital), Urgent Care Centers, Berkeley Urgent Care Center, Brentwood Urgent Care Center, Concord Urgent Care Center, San Ramon Urgent Care Center, Walnut Creek Urgent Care Center and Aspen Surgery Center.

Find out more about the patient billing fraud investigation against John Muir Health.

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation law firm with a tenacious drive for achieving real results for those harmed by corporate negligence and fraud. Since its founding in 1993, the firm’s determination has earned it numerous national accolades, awards and titles of “Most Feared Plaintiff’s Firm,” MVPs and Trailblazers of class-action law. More about the law firm and its successes can be found at www.hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contacts

Ashley Klann
pr@hbsslaw.com
206-268-9318

Hagens Berman


Release Summary
Hagens Berman attorneys warn Bay Area residents they may have been charged thousands by John Muir Health hospitals or ERs for illicit drug use tests.
Release Versions

Contacts

Ashley Klann
pr@hbsslaw.com
206-268-9318

More News From Hagens Berman

Hagens Berman: Ford Dealers File Class Action Alleging Major Warranty Reimbursement Shortfalls

DETROIT--(BUSINESS WIRE)--Ford dealers filed a class-action lawsuit against the automaker alleging underpaid warranty reimbursements, according to Hagens Berman....

Hagens Berman Investigating Rezolute, Inc. (RZLT) as Shares Tank 90% Amid Lead Asset Trial Failure

SAN FRANCISCO--(BUSINESS WIRE)--On December 11, 2025, investors in Rezolute, Inc. (NASDAQ: RZLT) saw the price of their shares crater as much as 90% during intraday trading after the company revealed the failure of its Phase 3 sunRIZE trial for ersodetug (“erso”). The company has billed this drug as a potential treatment for hypoglycemia caused by hyperinsulinism (“HI”). The news, analyst moves, and severe market reaction have prompted national shareholders rights firm Hagens Berman to open an...

KMX INVESTOR ALERT: CarMax (KMX) Securities Fraud Lawsuit Filed Over Alleged Concealed Demand Pull-Forward and Auto Finance Portfolio Risk – Hagens Berman

SAN FRANCISCO--(BUSINESS WIRE)--National investor rights law firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against CarMax, Inc. (NYSE: KMX) – January 2, 2026 – is rapidly approaching. The lawsuit alleges that CarMax and certain of its executives misled investors about the true stability and growth prospects of its core business, leading to two separate and massive stock crashes. Hagens Berman urges investors who suffered substantial...
Back to Newsroom